Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDK: The Outsourced Kinase of Chromosome Maintenance. | Biology (Basel) | 2022 | 35741398 | PubTator, text mining | PubMed |
| O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway. | Cancers (Basel) | 2022 | 35740678 | PubTator, text mining | PubMed |
| Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2. | Cancers (Basel) | 2022 | 35740522 | PubTator, text mining | PubMed |
| Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis. | BMC Med | 2022 | 35729600 | PubTator, text mining | PubMed |
| FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1. | Neuro Oncol | 2022 | 35723276 | PubTator, text mining | PubMed |
| Transthyretin-induced increase in circ_0007411 represses neovascularization of human retinal microvascular endothelial cells in hyperglycemia via the miR-548m/PTPN12/SKP1/EGFR pathway. | Ann Transl Med | 2022 | 35722376 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma. | BMC Cancer | 2022 | 35715770 | PubTator, text mining | PubMed |
| A Ubiquitin-Proteasome Gene Signature for Predicting Prognosis in Patients With Lung Adenocarcinoma. | Front Genet | 2022 | 35711913 | PubTator, text mining | PubMed |
| Ubiquitinating the way to T cell metabolism. | J Cell Biol | 2022 | 35695892 | PubTator, text mining | PubMed |
| Genetic Variations Controlling Regulatory T Cell Development and Activity in Mouse Models of Lupus-Like Autoimmunity. | Front Immunol | 2022 | 35693798 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers. | Front Genet | 2022 | 35685435 | PubTator, text mining | PubMed |
| Improving Homology-Directed Repair in Genome Editing Experiments by Influencing the Cell Cycle. | Int J Mol Sci | 2022 | 35682671 | PubTator, text mining | PubMed |
| New Therapeutic Strategies for Adult Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35681786 | PubTator, text mining | PubMed |
| Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies. | Cells | 2022 | 35681507 | PubTator, text mining | PubMed |
| Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival. | Respir Res | 2022 | 35672770 | PubTator, text mining | PubMed |
| HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | Life Sci | 2022 | 35671810 | PubTator, text mining | PubMed |
| Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells. | J Cell Biol | 2022 | 35670764 | PubTator, text mining | PubMed |
| Quantifying concordant genetic effects of de novo mutations on multiple disorders. | Elife | 2022 | 35666111 | PubTator, text mining | PubMed |
| A Temporal PROTAC Cocktail-Mediated Sequential Degradation of AURKA Abrogates Acute Myeloid Leukemia Stem Cells. | Adv Sci (Weinh) | 2022 | 35652200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=37